SCHEMBL2565052

SCHEMBL2565052

O=C(O)CCCCCNC(=O)OCc1cccc2c1Cc1ccccc1-2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.56
HTT P42858 1/20 0.52
PREP P48147 2/20 0.43
TGM2 P21980 1/20 0.42
PNMT P11086 1/20 0.42
FOLH1 Q04609 4/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
TPSAB1 Q15661 1/20 0.41
TPSD1 Q9BZJ3 1/20 0.41
TPSG1 Q9NRR2 1/20 0.41
HTR2C P28335 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
DPP8 Q6V1X1 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
MAPK1 P28482 1/20 0.39
PTGER4 P35408 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7343998 1.00 KMT2A (0.56) KMT2AHTTPREPTGM2PNMT
SCHEMBL8642710 0.99 KMT2A (0.54) KMT2AHTTPREPTGM2PNMT
SCHEMBL8046430 0.96 KMT2A (0.52) KMT2AHTTPREPTGM2PNMT
SCHEMBL28586408 0.95 HTT (0.57) KMT2AHTTPREPTGM2PNMT
SCHEMBL4663188 0.92 KMT2A (0.46) KMT2AHTTPREPTGM2PNMT
SCHEMBL29541016 0.91 HTT (0.47) KMT2AHTTPNMTFOLH1DRD2
SCHEMBL6030527 0.91 HTT (0.47) KMT2AHTTPNMTFOLH1DRD2
SCHEMBL6036900 0.89 PNMT (0.48) KMT2AHTTPREPTGM2PNMT
SCHEMBL230689 0.87 PNMT (0.45) KMT2AHTTPREPTGM2PNMT
Succinic Acid SCHEMBL28812246 0.87 HTT (0.43) KMT2AHTTPNMTFOLH1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110167599-B Compounds comprising self-sacrificing linking groups incorporating beta-galactosides 英托赛尔公司 2023-05-16 CN disclosed
CN-115192730-A Bispecific polypeptide nano-drug targeting PD-L1 and preparation method and application thereof 郑州大学 2022-10-18 CN disclosed
CN-110746490-B Polypeptide composition for blocking immune check point based on click reaction and preparation method and application thereof 国家纳米科学中心 2021-09-07 CN disclosed
CN-111349145-A Polypeptide molecule for preventing PD-L1 from being redistributed on tumor surface, preparation and application 北京工业大学 2020-06-30 CN disclosed
CN-110746490-A Polypeptide composition for blocking immune check point based on click reaction and preparation method and application thereof 国家纳米科学中心 2020-02-04 CN disclosed
EP-2560687-A2 COMPOSITIONS AND METHODS FOR SELECTIVE DELIVERY OF OLIGONUCLEOTIDE MOLECULES TO SPECIFIC NEURON TYPES Nlife Therapeutics S.L. (ES) 2013-02-27 EP disclosed
WO-2011131693-A2 COMPOSITIONS AND METHODS FOR SELECTIVE DELIVERY OF OLIGONUCLEOTIDE MOLECULES TO SPECIFIC NEURON TYPES NLIFE THERAPEUTICS, S.L. (ES) 2011-10-27 WO disclosed